Last reviewed · How we verify

NCT03319381

Geriatric Polytrauma SOP

Completed Last updated 24 October 2017
What this trial tests

trial testing Following new SOPs in Geriatrics in 311 participants. Completed in 31 December 2012.

Timeline
1 January 2000
Primary endpoint
31 December 2012
31 December 2012

Quick facts

Lead sponsorUniversity of Zurich
StatusCompleted
Study typeOBSERVATIONAL
Enrollment311
Start date1 January 2000
Primary completion31 December 2012
Estimated completion31 December 2012

Drugs / interventions tested

Conditions studied

Sponsor

University of Zurich

Who can join

65 and older, any sex, with Geriatrics. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigated whether there were improvements in the in-hospital mortality, infection rate, and rate of palliative care among geriatric trauma patients after the implementation of new standard operating procedures (SOPs) for the resuscitation room. These new SOPs, comprising early whole-body computed tomography (CT), damage control surgery, and the use of goal-directed coagulation management, were designed for severely injured adult trauma patients

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Implementation of new standard operating procedures for geriatric trauma patients with multiple injuries: a single level I trauma centre study.
    Peterer L, Ossendorf C, Jensen KO, Osterhoff G, et al · · 2019 · cited 20× · PMID 31856739 · DOI 10.1186/s12877-019-1380-z

Verify or expand the search:

Other recruiting trials for Geriatrics

Currently open trials in the same condition.

Other University of Zurich trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03319381.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing